Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Analysis of differential gene expression mediated by clozapine in human postmortem brains.

Lee BJ, Marchionni L, Andrews CE, Norris AL, Nucifora LG, Wu YC, Wright RA, Pevsner J, Ross CA, Margolis RL, Sawa A, Nucifora FC Jr.

Schizophr Res. 2017 Jul;185:58-66. doi: 10.1016/j.schres.2016.12.017. Epub 2016 Dec 27. Review.

PMID:
28038920
2.

Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia.

Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC.

PLoS One. 2016 Jan 22;11(1):e0146797. doi: 10.1371/journal.pone.0146797. eCollection 2016.

3.

Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for Schizophrenia.

Corcoba A, Steullet P, Duarte JM, Van de Looij Y, Monin A, Cuenod M, Gruetter R, Do KQ.

Int J Neuropsychopharmacol. 2015 Oct 3;19(3):pyv110. doi: 10.1093/ijnp/pyv110.

4.

Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients.

Monin A, Baumann PS, Griffa A, Xin L, Mekle R, Fournier M, Butticaz C, Klaey M, Cabungcal JH, Steullet P, Ferrari C, Cuenod M, Gruetter R, Thiran JP, Hagmann P, Conus P, Do KQ.

Mol Psychiatry. 2015 Jul;20(7):827-38. doi: 10.1038/mp.2014.88. Epub 2014 Aug 26.

PMID:
25155877
5.

Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Dai D, Wang Y, Yuan J, Zhou X, Jiang D, Li J, Zhang Y, Yin H, Duan S.

Biomed Rep. 2014 Sep;2(5):729-736. Epub 2014 Jun 30.

6.

Perineuronal nets protect fast-spiking interneurons against oxidative stress.

Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, Do KQ.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5. doi: 10.1073/pnas.1300454110. Epub 2013 May 13.

7.

Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine.

Cabungcal JH, Steullet P, Kraftsik R, Cuenod M, Do KQ.

Biol Psychiatry. 2013 Mar 15;73(6):574-82. doi: 10.1016/j.biopsych.2012.09.020. Epub 2012 Nov 7.

PMID:
23140664
8.

N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.

Shungu DC.

Biol Psychiatry. 2012 Jun 1;71(11):937-8. doi: 10.1016/j.biopsych.2012.03.025. No abstract available.

PMID:
22579304
9.

Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder.

Kulak A, Cuenod M, Do KQ.

Behav Brain Res. 2012 Jan 15;226(2):563-70. doi: 10.1016/j.bbr.2011.10.020. Epub 2011 Oct 20.

PMID:
22033334
10.

N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.

das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ.

Biol Psychiatry. 2012 Jun 1;71(11):1006-14. doi: 10.1016/j.biopsych.2011.07.035. Epub 2011 Sep 25.

PMID:
21945305
11.

Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia.

Lavoie S, Allaman I, Petit JM, Do KQ, Magistretti PJ.

PLoS One. 2011;6(7):e22875. doi: 10.1371/journal.pone.0022875. Epub 2011 Jul 28.

12.

Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT.

Berk M, Johansson S, Wray NR, Williams L, Olsson C, Haavik J, Bjerkeset O.

J Affect Disord. 2011 Jun;131(1-3):207-13. doi: 10.1016/j.jad.2010.12.019. Epub 2011 Jan 31.

PMID:
21277635
13.

No association between glutathione-synthesis-related genes and Japanese schizophrenia.

Hanzawa R, Ohnuma T, Nagai Y, Shibata N, Maeshima H, Baba H, Hatano T, Takebayashi Y, Hotta Y, Kitazawa M, Arai H.

Psychiatry Clin Neurosci. 2011 Feb;65(1):39-46. doi: 10.1111/j.1440-1819.2010.02157.x. Epub 2010 Nov 24.

14.

Assessing oxidative pathway genes as risk factors for bipolar disorder.

Fullerton JM, Tiwari Y, Agahi G, Heath A, Berk M, Mitchell PB, Schofield PR.

Bipolar Disord. 2010 Aug;12(5):550-6. doi: 10.1111/j.1399-5618.2010.00834.x.

PMID:
20712757
15.

Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese.

Ma J, Li DM, Zhang R, Yang XD, Gao CG, Lu SM, Wu SN, Wang L.

Schizophr Res. 2010 Jun;119(1-3):273-4. doi: 10.1016/j.schres.2009.12.017. Epub 2010 Jan 12. No abstract available.

PMID:
20061124
16.

Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population.

Che R, Tang W, Shao L, Zhao Q, Huang K, Tang R, Li Z, Zhao X, Ji W, Zhou G, Feng G, He L, Shi Y.

Psychiatr Genet. 2009 Oct;19(5):279-80. doi: 10.1097/YPG.0b013e32832cec76. No abstract available.

PMID:
19584774
17.

Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.

Butticaz C, Werge T, Beckmann JS, Cuénod M, Do KQ, Rivolta C.

Psychiatr Genet. 2009 Aug;19(4):201-8. doi: 10.1097/YPG.0b013e32832cef21.

PMID:
19455074
18.

Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.

Lavoie S, Chen Y, Dalton TP, Gysin R, Cuénod M, Steullet P, Do KQ.

J Neurochem. 2009 Mar;108(6):1410-22. doi: 10.1111/j.1471-4159.2009.05908.x. Epub 2009 Jan 22.

19.

Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.

Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, Iwata N.

Ann N Y Acad Sci. 2008 Oct;1139:63-9. doi: 10.1196/annals.1432.022.

PMID:
18991850
20.

Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population.

Matsuzawa D, Hashimoto K, Hashimoto T, Shimizu E, Watanabe H, Fujita Y, Iyo M.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):86-94. doi: 10.1002/ajmg.b.30776.

PMID:
18449862

Supplemental Content

Loading ...
Support Center